Latest Transformation News

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.

Whitebark Energy’s fresh petrophysical analysis reveals significant dry gas zones in its Warro Gas Field, boosting its commercial prospects and prompting a $750,000 capital raise to fast-track development.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.

Data # 3 Limited showcased strong FY25 financial results with record $3 billion gross sales and announced key board changes at its 2025 AGM. The company projects steady growth for FY26 despite some short-term challenges.

Lion Rock Minerals reports outstanding first-pass exploration results from its Minta Monazite and Rutile Project, revealing insitu rutile grades up to 2.2% and high-value mineral assemblages. These findings position Minta as a potentially world-class rutile deposit amid shifting global titanium markets.

Cash Converters has successfully completed the institutional component of a $25 million equity raising, positioning itself to acquire 29 franchise stores and expand its retail footprint.

Archer Materials has successfully demonstrated that its blood potassium Biochip can be fabricated on a silicon platform, matching clinical accuracy standards and accelerating its path to commercialisation.

Alligator Energy has commenced construction of its pivotal Samphire Field Recovery Trial, marking a significant shift from exploration to development. The company also bolstered its leadership team to support this growth phase and reported promising exploration results at its Big Lake Uranium Project.

Doctor Care Anywhere reports a 7.5% rise in consultations excluding secondary care and sustains positive cashflow for the second consecutive quarter, reaffirming ambitious medium-term growth targets.